BridgeMD
Compares treatment options for Endometriosis
Official title Robotic Versus Laparoscopic Surgery for Deep Endometriosis
ClinicalTrials.gov ID: NCT05179109
What this study is testing
- What it's testing
- The objective of this study is to examine whether robot-assisted laparoscopy is superior compared to conventional laparoscopy as regards to patient outcome.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only
You may be able to join if
- ASA (American Society of Anesthesiologists physical status classification) 1-3
- Diagnosed deep endometriosis (MRI)
- Patient has symptoms
- Operative treatment is indicated
- Patient is able to give informed consent
You likely can't join if
- ASA \> 3
- Recurring rectosigmoid endometriosis
The study team makes the final eligibility decision.
Where it's taking place
- Oulu, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oulu, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.